Which method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?

References

• Ammassari , A. , Trotta , M.P. , Murri , R. , Castelli , F. , Narciso , P. Noto , P. 2002 . Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature . Journal of Acquired Immune Deficiency Syndromes , 31 ( Suppl. 3 ) : S123 – S127 .
   PubMed Web of Science ®Google Scholar
• Bangsberg , D.R. 2006 . Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression . Clinical Infectious Diseases , 43 : 939 – 941 .
   PubMed Web of Science ®Google Scholar
• Bocket , L. , Cheret , A. , Deuffic-Burban , S. , Choisy , P. , Gerard , Y. , de , l. Tribonniere , X. 2005 . Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness . Antiviral Therapy , 10 : 247 – 254 .
   PubMed Web of Science ®Google Scholar
• Burger , D.M. , Hoetelmans , R.M. , Hugen , P.W. , Mulder , J.W. , Meenhorst , P.L. Koopmans , P.P. 1998 . Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy . Antiviral Therapy , 3 : 215 – 220 .
   PubMed Web of Science ®Google Scholar
• Burger , D.M. , Hugen , P.W. , Aarnoutse , R.E. , Hoetelmans , R.M. , Jambroes , M. Nieuwkerk , P.T. 2003 . Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations . Therapeutic Drug Monitoring , 25 : 73 – 80 .
   PubMed Web of Science ®Google Scholar
• Carrieri , P. , Cailleton , V. , Le Moing , V. , Spire , B. , Dellamonica , P. Bouvet , E. 2001 . The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort . Journal of Acquired Immune Deficiency Syndromes , 28 : 232 – 239 .
   PubMed Web of Science ®Google Scholar
• de Bruin , M. , Hospers , H.J. , van den Borne , H.W. , Kok , G. and Prins , J.M. 2005 . Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: A pilot study . AIDS Patient Care STDS , 19 : 384 – 394 .
   PubMed Web of Science ®Google Scholar
• de Maat , M.M. , Nellen , J.F. , Huitema , A.D. , Wit , F.W. , Mulder , J.W. Prins , J.M. 2004 . Race is not associated with nevirapine pharmacokinetics . Therapeutic Drug Monitoring , 26 : 456 – 458 .
   PubMed Web of Science ®Google Scholar
• de Vries-Sluijs , T.E. , Dieleman , J.P. , Arts , D. , Huitema , A.D. , Beijnen , J.H. Schutten , M. 2003 . Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population . Clinical Pharmacokinetics , 42 : 599 – 605 .
   PubMed Web of Science ®Google Scholar
• Dray-Spira , R. , Spire , B. , Heard , I. and Lert , F. 2007 . Heterogeneous response to HAART across a diverse population of people living with HIV: Results from the ANRS-EN12-VESPA Study . AIDS , 21 ( Suppl. 1 ) : S5 – S12 .
   PubMed Web of Science ®Google Scholar
• Gross , R. , Yip , B. , Lo Re , V. III , Wood , E. , Alexander , C.S. Harrigan , P.R. 2006 . A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression . Journal of Infectious Diseases , 194 : 1108 – 1114 .
   PubMed Web of Science ®Google Scholar
• Grossberg , R. , Zhang , Y. and Gross , R. 2004 . A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV . Journal of Clinical Epidemiology , 57 : 1107 – 1110 .
   PubMed Web of Science ®Google Scholar
• Hugen , P.W. , Burger , D.M. , Aarnoutse , R.E. , Baede , P.A. , Nieuwkerk , P.T. Koopmans , P.P. 2002 . Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance . Therapeutic Drug Monitoring , 24 : 579 – 587 .
   PubMed Web of Science ®Google Scholar
• Johnson , J.A. 1997 . Influence of race or ethnicity on pharmacokinetics of drugs . Journal of Pharmaceutical Sciences , 86 : 1328 – 1333 .
   PubMed Web of Science ®Google Scholar
• Kalichman , S.C. , Ramachandran , B. and Catz , S. 1999 . Adherence to combination antiretroviral therapies in HIV patients of low health literacy . Journal of General Internal Medicine , 14 : 267 – 273 .
   PubMed Web of Science ®Google Scholar
• Kaslow , R.A. and McNicholl , J.M. 1999 . Genetic determinants of HIV-1 infection and its manifestations . Proceedings of the Association of American Physicians , 111 : 299 – 307 .
   PubMedGoogle Scholar
• Kleeberger , C.A. , Phair , J.P. , Strathdee , S.A. , Detels , R. , Kingsley , L. and Jacobson , L.P. 2001 . Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study . Journal of Acquired Immune Deficiency Syndromes , 26 : 82 – 92 .
   PubMed Web of Science ®Google Scholar
• Liechty , C.A. , Alexander , C.S. , Harrigan , P.R. , Guzman , J.D. , Charlebois , E.D. Moss , A.R. 2004 . Are untimed antiretroviral drug levels useful predictors of adherence behavior? . AIDS , 18 : 127 – 129 .
   PubMed Web of Science ®Google Scholar
• Lucas , G.M. , Chaisson , R.E. and Moore , R.D. 1999 . Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions . Annals of Internal Medicine , 131 : 81 – 87 .
   PubMed Web of Science ®Google Scholar
• Mannheimer , S. , Friedland , G. , Matts , J. , Child , C. and Chesney , M. 2002 . The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials . Clinical Infectious Diseases , 34 : 1115 – 1121 .
   PubMed Web of Science ®Google Scholar
• Marzolini , C. , Telenti , A. , Decosterd , L.A. , Greub , G. , Biollaz , J. and Buclin , T. 2001 . Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients . AIDS , 15 : 71 – 75 .
   PubMed Web of Science ®Google Scholar
• Miller , L.G. , Liu , H. , Hays , R.D. , Golin , C.E. , Ye , Z. Beck , C.K. 2003 . Knowledge of antiretroviral regimen dosing and adherence: A longitudinal study . Clinical Infectious Diseases , 36 : 514 – 518 .
   PubMed Web of Science ®Google Scholar
• Nellen , J.F. , Wit , F.W. , de Wolf , F. , Jurriaans , S. , Lange , J.M. and Prins , J.M. 2004 . Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-Infected patients in The Netherlands . Journal of Acquired Immune Deficiency Syndromes , 36 : 943 – 950 .
   PubMed Web of Science ®Google Scholar
• Nieuwkerk , P. , Gisolf , E. , Sprangers , M. and Danner , S. 2001a . Adherence over 48 weeks in an antiretroviral clinical trial: Variable within patients, affected by toxicities and independently predictive of virological response . Antiviral Therapy , 6 : 97 – 103 .
   PubMed Web of Science ®Google Scholar
• Nieuwkerk , P.T. and Oort , F.J. 2005 . Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis . Journal of Acquired Immune Deficiency Syndromes , 38 : 445 – 448 .
   PubMed Web of Science ®Google Scholar
• Nieuwkerk , P.T. , Sprangers , M.A. , Burger , D.M. , Hoetelmans , R.M. , Hugen , P.W. Danner , S.A. 2001b . Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study . Archives of Internal Medicine , 161 : 1962 – 1968 .
   PubMed Web of Science ®Google Scholar
• Oette , M. , Kroidl , A. , Gobels , K. , Stabbert , A. , Menge , M. Sagir , A. 2006 . Predictors of short-term success of antiretroviral therapy in HIV infection . Journal of Antimicrobial Chemotherapy , 58 : 147 – 153 .
   PubMed Web of Science ®Google Scholar
• Parienti , J.J. , Verdon , R. , Bazin , C. , Bouvet , E. , Massari , V. and Larouze , B. 2001 . The pills identification test: A tool to assess adherence to antiretroviral therapy . JAMA , 285 : 412
   PubMed Web of Science ®Google Scholar
• Park , W.B. , Choe , P.G. , Kim , S.H. , Jo , J.H. , Bang , J.H. Kim , H.B. 2007 . One-year adherence to clinic visits after highly active antiretroviral therapy: A predictor of clinical progress in HIV patients . Journal of Internal Medicine , 261 : 268 – 275 .
   PubMed Web of Science ®Google Scholar
• Paterson , D.L. , Swindells , S. , Mohr , J. , Brester , M. , Vergis , E.N. Squier , C. 2000 . Adherence to protease inhibitor therapy and outcomes in patients with HIV infection . Annals of Internal Medicine , 133 : 21 – 30 .
   PubMed Web of Science ®Google Scholar
• Saul , J. , Erwin , J. , Sabin , C.A. , Kulasegaram , R. and Peters , B.S. 2001 . The relationships between ethnicity, sex, risk group, and virus load in human immunodeficiency virus type 1 antiretroviral-naive patients . Journal of Infectious Diseases , 183 : 1518 – 1521 .
   PubMed Web of Science ®Google Scholar
• Schaeffeler , E. , Eichelbaum , M. , Brinkmann , U. , Penger , A. , Asante-Poku , S. Zanger , U.M. 2001 . Frequency of C3435T polymorphism of MDR1 gene in African people . Lancet , 358 : 383 – 384 .
   PubMed Web of Science ®Google Scholar
• Smith , P.R. , Sarner , L. , Murphy , M. , James , B. , Thomas , J.M. Skinner , C.J. 2003 . Ethnicity and discordance in plasma HIV-1 RNA viral load and CD4+ lymphocyte count in a cohort of HIV-1-infected individuals . Journal of Clinical Virology , 26 : 101 – 107 .
   PubMed Web of Science ®Google Scholar
• Stone , V.E. , Hogan , J.W. , Schuman , P. , Rompalo , A.M. , Howard , A.A. Korkontzelou , C. 2001 . Antiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: Survey of women in the her study . Journal of Acquired Immune Deficiency Syndromes , 28 : 124 – 131 .
   PubMed Web of Science ®Google Scholar
• van den Berg , J.B. , Hak , E. , Vervoort , S.C. , Hoepelman , I.M. , Boucher , C.A. Schuurman , R. 2005 . Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy . HIV Medicine , 6 : 299 – 306 .
   PubMed Web of Science ®Google Scholar
• van Sighem , A.I. , van de Wiel , M.A. , Ghani , A.C. , Jambroes , M. , Reiss , P. Gyssens , I.C. 2003 . Mortality and progression to AIDS after starting highly active antiretroviral therapy . AIDS , 17 : 2227 – 2236 .
   PubMed Web of Science ®Google Scholar
• Wolf , M.S. , Davis , T.C. , Arozullah , A. , Penn , R. , Arnold , C. Sugar , M. 2005 . Relation between literacy and HIV treatment knowledge among patients on HAART regimens . AIDS Care , 17 : 863 – 873 .
   PubMed Web of Science ®Google Scholar
• Yuan , Y. , L'italien , G. , Mukherjee , J. and Iloeje , U.H. 2006 . Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort . HIV Medicine , 7 : 156 – 162 .
   PubMed Web of Science ®Google Scholar